A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)

NCT00943371 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MK6349
DRUG: Comparator: Placebo to MK6349

Sponsor

Merck Sharp & Dohme LLC